What's breaking now, across thousands of outlets.
The failure of “del-desiran,” which Novartis got through a $12 billion acquisition, could raise questions about the company’s business development acumen, according to one analyst.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
A new program developed by University of Alberta researchers is showing promise in helping stroke survivors stride toward recovery after leaving the hospital.
QIMR Berghofer researchers have identified a strong genetic link between gut-related health conditions and depression in a study offering new insights into why physical illnesses often accompany the…
The most comprehensive catalog of exploding white dwarf stars ever assembled has revealed new clues about dark energy, the mysterious force driving the universe's accelerating expansion.
For many in the workforce, spending hours at a computer is an unavoidable part of daily life. Sitting for prolonged periods in the same position can contribute to low back pain (LBP), which affects up…
Since China banned the import of plastic waste in 2018, plastic pollution has been having a growing impact on the people and ecosystems of Latin America.
How did a photon survive a journey of more than 2 billion light-years when, according to known physics, it should have been absorbed long before reaching Earth?
